Northwest Biotherapeutics, a biotechnology company developing DCVax personalized immune therapies for solid tumor cancers, applied for certification of the manufacturing facility in Sawston, UK with the Medicines and Healthcare Products Regulatory ...
Northwest Biotherapeutics announced the Company has acquired Flaskworks, a company that has developed a system to close and automate the manufacturing of cell therapy products such as DCVax®.